Overview
Smart money at a glance
Filings to Oct 1, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 4 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Oct 1- Open
- $87.79
- 52-wk high
- $135.24
- High
- $89.92
- 52-wk low
- $77.55
- Low
- $86.60
- Prev close
- $86.88
- Mkt cap
- $37.75B
- P/E
- 152.1x
- Volume
- 3.08M
- Fwd P/E
- 51.8x
- Beta
- 1.01
- Div yield
- 0.28%
- P/S
- 10.9x
- P/B
- 8.1x
- Profit margin
- +10.2%
- Op margin
- +9.1%
- ROE
- +5.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about CCJ filings
Are insiders buying or selling Cameco Corp (CCJ) stock?
Neither. Cameco Corp (CCJ) insiders filed no open-market purchases or sales in the 90 days to Oct 1, 2026, according to SEC Form 4 filings.
Which members of Congress have traded CCJ recently?
None. No member of Congress disclosed a CCJ trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this CCJ smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position.
What funds are doing
Buys/Adds (3)
- DS

D.E. Shaw
$98.4M
added
- MI

Millennium
$39.2M
added
- BA

Balyasny
$33.5M
bought
How top traders are positioned
No tracked top-trader positions in CCJ right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 50.0% below what analysts expected.
Earnings per share
$0.26 expected
Reports Nov 4, 2026, in 34 days
Estimates as of Oct 1, 2026
EPS expected
$0.24 to $0.37
Revenue expected
5 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Jun 2025 |
|---|---|
| What came in | |
| Revenue | $877.0M |
| Cost of what it sold | $619.9M |
| Gross profit | $257.1M |
| What it spent | |
| Research and development | $708.0K |
| Sales and admin | $96.4M |
| Other operating costs | -$6.0M |
| Total operating expenses | $91.1M |
| What was left | |
| Operating profit | $166.0M |
| Interest on debt | $17.4M |
| Profit before tax | $392.0M |
| Tax | $71.1M |
| Net profit | $320.9M |
| EBITDA | $500.8M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace